Skip to content
This GLP
Updated September 2026Three conditions on one figure

SurpassMD review

The figure depends on eligibility, medication, dose and provider approval, all stated.

The verdict

SurpassMD publishes semaglutide as low as $124 a month and tirzepatide at $184, read August 2026, for eligible patients. The site states actual pricing depends on medication, dose and provider approval. Coverage is 51 jurisdictions.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
States
51
From
$124/mo
Prescription
Required
Compounded
Yes — not FDA-approved
Availability
51 jurisdictions

SurpassMD sells both molecules by injection across 51 jurisdictions. Both figures carry stated conditions. Neither is a settled rate.

  1. Who writes the prescription, and what do they see?

    Provider approval is named as one of the three things that moves the price. That makes the clinician part of the pricing, which the site says outright.

    Four conditions sit on one number: eligibility, medication, dose and approval. Listing them is honest. It also means the figure describes very little on its own.

  2. What happens when the dose goes up?

    Dose is named as a variable that changes the price. What it changes it to is not published. Direction without a destination is half an answer.

  3. What the price includes

    Six months at $124 is $744 at best. Tirzepatide at $184 is $1,104 at best. Both totals assume every condition resolves favorably. Ask what your own figure is before ordering.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: The conditions are listed, not hidden
  • Strength: Coverage across 51 jurisdictions
  • Strength: Both molecules carry a figure
  • Limitation: Eligibility gates the published rate
  • Limitation: Dose changes it by an unstated amount
  • Limitation: Provider approval also moves it
  • Limitation: No compounding pharmacy is named

What the evidence says about this kind of treatment

The assessment above is about SurpassMD. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who will ask what their own approved figure is.
Wrong for
A reader planning six months from the published rate.

How SurpassMD compares

SellerWho it suitsGo
Somira HealthReaders who want the rate pinned across an escalationSee Somira Health
SunlightReaders who want a rate guaranteed against increases and will count the fillsSee Sunlight
TeleCareSpotReaders confident of approval who want a flat all-in rateSee TeleCareSpot
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Fidelity Medical ClinicFORMFoundFridaysGalaGenesis Health

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

Will I pay $124?
Only if eligible, and the site states pricing also depends on medication, dose and provider approval.
Does the price rise with the dose?
Dose is named as a factor. What it raises the figure to is not published.
Where does SurpassMD ship?
Fifty-one jurisdictions are recorded.
Is SurpassMD legit?
SurpassMD is a GLP-1 telehealth sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
Is SurpassMD expensive compared with other GLP-1 telehealth sellers?
SurpassMD publishes a starting figure of $124/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts SurpassMD below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Glenn TorresStandards editor · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from SurpassMD’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.